Sfoglia per Rivista HAEMATOLOGICA
A novel high dose chemotherapy strategy with Bendamustine in adjunct to Etoposide, Aracytin and Melphalan (BeEAM) followed by autologous stem cell rescue is safe and highly effective for the treatment of resistant/relapsed lymphoma patients: a phase I-II study on 33 patients
2010 G., Visani; L., Malerba; P. M., Stefani; S., Capria; P., Galieni; F., Gaudio; G., Specchia; G., Meloni; F., Gherlinzoni; C., Giardini; S., Falcioni; F., Loscocco; F., Cuberli; M., Gobbi; A., Santoro; B., Sarina; Rocchi, MARCO BRUNO LUIGI; A., Isidori
CD34 ABSOLUTE COUNT AND SUBSETTING STANDARDIZATION
1998 Papa, S; Canonico, B; Schmitz, G; Gratama, J. W.
Cytomegalovirus reactivation after autologous stem cell transplant for b-cell malignancies: something to deal with. A prospective study on 92 consecutive patients
2010 G., Visani; L., Malerba; B., Guiducci; S., Barulli; M., Lucesole; F., Loscocco; I., Tommasini; G., Polenta; P., Tontini; Rocchi, MARCO BRUNO LUIGI; A., Isidori
Dose-dense therapy with non-pegylated liposomal doxorubicin (R-comp 14 vs. 21) is feasible and effective for elderly patients with newly diagnosed aggresive B-cell non-Hodgkin lymphoma
2010 G., Visani; F., Merli; F., Angrilli; F., Ferrara; F., Ilariucci; S., Falorio; G., Fioritoni; F., Alesiani; M., Brunori; F., Pollio; M., Celentano; D., Cangini; S., Ronconi; M., Catarini; G., Giglio; D., Vallisa; A., Arcari; D., Bernardi; R., Paolini; B., Guiducci; S., Barulli; M., Lucesole; Rocchi, MARCO BRUNO LUIGI; F., Loscocco; F., D'Adamo; A., Isidori
IN THE HUMAN GENOME, ONLY FEW GENES CAN BE A TARGET FOR DUPLICATION ENCODING A NUCLEAR LOCALIZATION SIGNAL
2008 A., Liso A; Bogliolo, Alessandro; Freschi, Valerio; F., Massenzio; C., Fesce; M. P., Martelli; G., Specchia; M. F., Martelli; B., Falini
Limiting dilution analysis of IL-2 producing cells: I. Studies of normal human peripheral blood.
1992 Moretti, L; Giuliodori, L; Stramigioli, S; Luchetti, Francesca; Baldi, A; Sparaventi, G.
The K562 chronic myeloid cell line undergoes apoptosis in response to interferon-α.
1998 Luchetti, Francesca; Gregorini, Armando; Papa, Stefano; Burattini, Sabrina; Canonico, Barbara; M., Valentini; Falcieri, Elisabetta
TS, MTHFR AND XRCC1 GENETIC VARIANTS AFFECT THE CLINICAL COURSE OF MDS PATIENTS IRRESPECTIVELY OF IPSS RISK
2015 Loscocco, F; Visani, G; Giacomini, E; Ruzzo, Annamaria; Voso, Mt; Fabiani, E; Finelli, C; Graziano, F; Barulli, S; Volpe, A; Magro, D; Piccaluga, Pp; Fuligni, F; Vignetti, M; Fazi, P; Piciocchi, A; Clissa, C; Gabucci, E; Rocchi, MARCO BRUNO LUIGI; Magnani, Mauro; Isidori, A.
XRCC1 399GG GENOTYPE PREDICTS LONG LASTING CR AND SIGNIFICANTLY LONGER OVERALL SURVIVAL IN RESISTANT LYMPHOMA TREATED WITH BENDA-BEAM AND ASCT
2015 Visani, G; Loscocco, F; Giacomini, E; Ruzzo, Annamaria; Stefani, Pm; Capria, S; Galieni, P; Gaudio, F; Specchia, G; Meloni, G; Gherlinzoni, F; Falcioni, S; Gonella, R; Gobbi, M; Sarina, B; Santoro, A; Fuligni, F; Nicolini, G; D'Adamo, F; Clissa, C; Gabucci, E; Piccaluga, Pp; Magnani, Mauro; Isidori, A.
XRCC1 399GG GENOTYPE PREDICTS SIGNIFICANTLY LONGER OVERALL SURVIVAL AND LONG LASTING CR IN RESISTANT LYMPHOMA TREATED WITH BENDA-BEAM AND ASCT
2015 Visani, G; Loscocco, F; Giacomini, E; Ruzzo, Annamaria; Stefani, Pm; Capria, S; Galieni, P; Gaudio, F; Specchia, G; Meloni, G; Gherlinzoni, F; Falcioni, S; Gonella, R; Gobbi, M; Sarina, B; Santoro, A; Fuligni, F; Nicolini, G; D'Adamo, F; Clissa, C; Gabucci, E; Piccaluga, Pp; Magnani, Mauro; Isidori, A.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A novel high dose chemotherapy strategy with Bendamustine in adjunct to Etoposide, Aracytin and Melphalan (BeEAM) followed by autologous stem cell rescue is safe and highly effective for the treatment of resistant/relapsed lymphoma patients: a phase I-II study on 33 patients | 1-gen-2010 | G., Visani; L., Malerba; P. M., Stefani; S., Capria; P., Galieni; F., Gaudio; G., Specchia; G., Meloni; F., Gherlinzoni; C., Giardini; S., Falcioni; F., Loscocco; F., Cuberli; M., Gobbi; A., Santoro; B., Sarina; Rocchi, MARCO BRUNO LUIGI; A., Isidori | |
CD34 ABSOLUTE COUNT AND SUBSETTING STANDARDIZATION | 1-gen-1998 | Papa, S; Canonico, B; Schmitz, G; Gratama, J. W. | |
Cytomegalovirus reactivation after autologous stem cell transplant for b-cell malignancies: something to deal with. A prospective study on 92 consecutive patients | 1-gen-2010 | G., Visani; L., Malerba; B., Guiducci; S., Barulli; M., Lucesole; F., Loscocco; I., Tommasini; G., Polenta; P., Tontini; Rocchi, MARCO BRUNO LUIGI; A., Isidori | |
Dose-dense therapy with non-pegylated liposomal doxorubicin (R-comp 14 vs. 21) is feasible and effective for elderly patients with newly diagnosed aggresive B-cell non-Hodgkin lymphoma | 1-gen-2010 | G., Visani; F., Merli; F., Angrilli; F., Ferrara; F., Ilariucci; S., Falorio; G., Fioritoni; F., Alesiani; M., Brunori; F., Pollio; M., Celentano; D., Cangini; S., Ronconi; M., Catarini; G., Giglio; D., Vallisa; A., Arcari; D., Bernardi; R., Paolini; B., Guiducci; S., Barulli; M., Lucesole; Rocchi, MARCO BRUNO LUIGI; F., Loscocco; F., D'Adamo; A., Isidori | |
IN THE HUMAN GENOME, ONLY FEW GENES CAN BE A TARGET FOR DUPLICATION ENCODING A NUCLEAR LOCALIZATION SIGNAL | 1-gen-2008 | A., Liso A; Bogliolo, Alessandro; Freschi, Valerio; F., Massenzio; C., Fesce; M. P., Martelli; G., Specchia; M. F., Martelli; B., Falini | |
Limiting dilution analysis of IL-2 producing cells: I. Studies of normal human peripheral blood. | 1-gen-1992 | Moretti, L; Giuliodori, L; Stramigioli, S; Luchetti, Francesca; Baldi, A; Sparaventi, G. | |
The K562 chronic myeloid cell line undergoes apoptosis in response to interferon-α. | 1-gen-1998 | Luchetti, Francesca; Gregorini, Armando; Papa, Stefano; Burattini, Sabrina; Canonico, Barbara; M., Valentini; Falcieri, Elisabetta | |
TS, MTHFR AND XRCC1 GENETIC VARIANTS AFFECT THE CLINICAL COURSE OF MDS PATIENTS IRRESPECTIVELY OF IPSS RISK | 1-gen-2015 | Loscocco, F; Visani, G; Giacomini, E; Ruzzo, Annamaria; Voso, Mt; Fabiani, E; Finelli, C; Graziano, F; Barulli, S; Volpe, A; Magro, D; Piccaluga, Pp; Fuligni, F; Vignetti, M; Fazi, P; Piciocchi, A; Clissa, C; Gabucci, E; Rocchi, MARCO BRUNO LUIGI; Magnani, Mauro; Isidori, A. | |
XRCC1 399GG GENOTYPE PREDICTS LONG LASTING CR AND SIGNIFICANTLY LONGER OVERALL SURVIVAL IN RESISTANT LYMPHOMA TREATED WITH BENDA-BEAM AND ASCT | 1-gen-2015 | Visani, G; Loscocco, F; Giacomini, E; Ruzzo, Annamaria; Stefani, Pm; Capria, S; Galieni, P; Gaudio, F; Specchia, G; Meloni, G; Gherlinzoni, F; Falcioni, S; Gonella, R; Gobbi, M; Sarina, B; Santoro, A; Fuligni, F; Nicolini, G; D'Adamo, F; Clissa, C; Gabucci, E; Piccaluga, Pp; Magnani, Mauro; Isidori, A. | |
XRCC1 399GG GENOTYPE PREDICTS SIGNIFICANTLY LONGER OVERALL SURVIVAL AND LONG LASTING CR IN RESISTANT LYMPHOMA TREATED WITH BENDA-BEAM AND ASCT | 1-gen-2015 | Visani, G; Loscocco, F; Giacomini, E; Ruzzo, Annamaria; Stefani, Pm; Capria, S; Galieni, P; Gaudio, F; Specchia, G; Meloni, G; Gherlinzoni, F; Falcioni, S; Gonella, R; Gobbi, M; Sarina, B; Santoro, A; Fuligni, F; Nicolini, G; D'Adamo, F; Clissa, C; Gabucci, E; Piccaluga, Pp; Magnani, Mauro; Isidori, A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile